Description
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
Product Unit Size | Cost | Quantity | Stock |
---|
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
Cas No. | 1874276-76-2 |
---|---|
Purity | ≥98% |
Formula | C22H23F3N8O |
Formula Wt. | 472.48 |
Chemical Name | LXS-196 |
IUPAC Name | 3-Amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]-2-pyrazinecarboxamide |
Synonym | LXS 196, LXS196, NVP-LXS196, Darovasertib |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hydrophobic β-lactam; penicillin binding prote...
Polyphenol found in many plants and foods.
Found in cruciferous vegetables.
Purine derivative; CDK inhibitor.
Endogenous peptide fragment, immunostimulant; ...
FIASMA; α1- and β1/2-adrenergic antagonist.
Cannabinoid receptor 2 selective agonist.
Podophyllotoxin derivative; topoisomerase II in...
Endogenous peptide hormone inolved in gastric e...
Synthetic progestogen; contraceptive.
beta-catenin inhibitor
Macrolide originally produced by Streptomyces; ...
Antimicrobial peptide found in bee and wasp ven...
Diterpene found in Taxus; potential microtubule...
NSAID; COX-1/2 inhibitor.
CDK2 inhibitor.
ASK1 inhibitor.
PDE5/6 inhibitor.
Tetracyclic sesterpenoid phytotoxin.
5-HT2A antagonist, potential α1-adrenergic ant...